Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DS

Daryl Lynn Smith — 13 Patents

Eli Lilly: 7 patents #497 of 2,858Top 20%
NPNps Pharmaceuticals: 6 patents #18 of 103Top 20%
Astrazeneca Ab: 1 patents #1,022 of 1,971Top 55%
Fishers, IN: #72 of 589 inventorsTop 15%
Indiana: #2,741 of 33,936 inventorsTop 9%
Overall (All Time): #362,438 of 4,157,543Top 9%
13 Patents All Time
Daryl Lynn Smith has been granted 13 US patents while listed as an inventor at Eli Lilly. The first was granted in 2000 and the most recent in October 2023. Daryl Lynn Smith ranks #362,438 of 4,157,543 US inventors in our database (top 8.7%). Patent records list Daryl Lynn Smith in Fishers, IN, US.

Patents per Year

Patents granted per year, 2000 to 2023Bar chart with a peak of 2 patents in 2003.peak 22000: 1 patents20002002: 1 patents20022003: 2 patents20032006: 2 patents20062007: 2 patents20072009: 1 patents20092010: 1 patents20102019: 1 patents20192022: 1 patents20222023: 1 patents2023

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11773067 (Trifluoromethyl)pyrimidine-2-amine compounds Leonard Larry Winneroski, Jr. 2023-10-03 $1,234,141,000
11414389 (trifluoromethyl)pyrimidine-2-amine compounds Leonard Larry Winneroski, Jr. 2022-08-16 $2,006,412,000
10227310 Ghrelin 0-acyl transferase inhibitors Christopher Stanley Galka, Erik James Hembre, Nicholas Allan Honigschmidt, Maria Angeles Martinez-Grau, Gema Ruano Plaza +2 more 2019-03-12 $585,169,000
7655641 Sulfonamide derivatives as PPAR modulators Scott Eugene Conner, Lynn Stacy Gossett, Jonathan Edward Green, Winton D. Jones, Nathan B. Mantlo +8 more 2010-02-02 $74,925,000
7595339 CB1 modulator compounds Jennifer R. Allen, Albert Amegadzie, Kevin Matthew Gardinier, George Stuart Gregory, Stephen Hitchcock +2 more 2009-09-29 $67,969,000
7282501 Modulators of peroxisome proliferator activated receptors (PPAR) Lynn Stacy Gossett, Jonathan Edward Green, James Robert Henry, Winton D. Jones, Donald P. Matthews +3 more 2007-10-16 $57,366,000
7276516 CB1 antagonist compounds Jennifer R. Allen, Albert Amegadzie, Kevin Matthew Gardinier, George Stuart Gregory, Steven Andrew Hitchcock +2 more 2007-10-02 $196,781,000
7112595 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists Bradford Wagenen, Thomas Stormann, Scott Moe, Susan M. K. Sheehan, Donald McLeod +8 more 2006-09-26
7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases Bradford C. Van Wagenen, Scott Moe, Susan M. K. Sheehan, Irina Shcherbakova, Ruth J. Walton +4 more 2006-05-30 $4,638,000
6660753 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists Bradford C. Van Wagenen, Thomas Stormann, Scott Moe, Susan M. K. Sheehan, Donald McLeod +2 more 2003-12-09 $16,141,000
6617358 Anticonvulsant and central nervous system-depressing bis(fluorophenyl)alkylamides and their uses Manuel F. Balandrin, Bradford C. VanWagenen, Linda D. Artman, Alan L. Mueller, Scott Moe 2003-09-09 $15,881,000
6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases Bradford C. Van Wagenen, Scott Moe, Susan M. K. Sheehan, Irina Shcherbakova, Richard Travato +4 more 2002-08-06 $10,559,000
6017965 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases Alan L. Mueller, Manuel F. Balandrin, Bradford C. VanWagenen, Scott Moe, Eric G. DelMar +2 more 2000-01-25 $5,465,000